Fosinopril Sodium Tablet
Product Images NDC 71335-0187

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 71335-0187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 01)

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 01)
Chemical structure of Fosinopril, showing its molecular arrangement including phenyl, phosphate, and sodium-containing groups.*
FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 02)

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 02)
A data table showing clinical adverse events from placebo-controlled hypertension trials comparing Fosinopril Sodium and placebo. It lists incidence and discontinuation rates for cough, dizziness, and nausea/vomiting among 688 Fosinopril Sodium subjects and 184 placebo subjects.*
FDA Label Image

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 03)

Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 03)
A data table listing the incidence and discontinuation rates of clinical adverse events in placebo-controlled trials for heart failure. The table compares Fosinopril Sodium (N=361) and placebo (N=373) groups, showing events such as dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, diarrhea, chest pain, upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbances, and weakness.*
FDA Label Image

Label Image (Lbl713350187)

Label Image (Lbl713350187)
Label of Fosinopril Sodium 20 mg tablet from Bryant Ranch Prepack, showing the product name, strength, dosage form, and comparison to Monopril 20 mg tablets by InvaGen Pharmaceuticals. The label includes storage instructions (20-25°C), a warning to keep out of reach of children, lot number 1523487, and the NDC 71335-0187 in barcode format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.